View in EDS HTML Full Text PDF Full Text

Cytomegalovirus immunoglobulin serology prevalence in patients with newly diagnosed multiple myeloma treated within the GMMG-MM5 phase III trial.

Saved in:
Bibliographic Details
Title: Cytomegalovirus immunoglobulin serology prevalence in patients with newly diagnosed multiple myeloma treated within the GMMG-MM5 phase III trial.
Authors: Salwender, Hans1 (AUTHOR) h.salwender@asklepios.com, Weinhold, Niels2 (AUTHOR), Benner, Axel3 (AUTHOR), Miah, Kaya3 (AUTHOR), Merz, Maximilian4 (AUTHOR), Haenel, Mathias5 (AUTHOR), Jehn, Christian6 (AUTHOR), Mai, Elias2 (AUTHOR), Menis, Ekaterina2 (AUTHOR), Blau, Igor7 (AUTHOR), Scheid, Christof8 (AUTHOR), Hose, Dirk9 (AUTHOR), Seckinger, Anja9 (AUTHOR), Luntz, Steffen10 (AUTHOR), Besemer, Britta11 (AUTHOR), Munder, Markus12 (AUTHOR), Brossart, Peter13 (AUTHOR), Glass, Bertram14 (AUTHOR), Lindemann, Hans-Walter15 (AUTHOR), Weisel, Katja16 (AUTHOR)
Source: Hematology. Dec2024, Vol. 29 Issue 1, p1-7. 7p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:10245332
DOI:10.1080/16078454.2024.2320006